This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Clifton Earl Hyman: Innovator in Pharmaceutical Advances
Introduction
Clifton Earl Hyman is a distinguished inventor based in Durham, NC, with a notable contribution to the field of pharmaceuticals. With two patents to his name, Hyman has played a significant role in developing innovative compounds that have implications for therapeutic treatments.
Latest Patents
Hyman's latest patents showcase his expertise and creativity in drug formulation and therapeutic applications. The first patent, titled "Pyrimidinones as melanin concentrating hormone receptor 1," describes a compound of formula (Ia) that includes a pharmaceutically acceptable salt or solvate. This invention outlines formulations, processes for preparation, and methods for administering these compounds to mammals, indicating potential benefits in medical therapies.
His second patent, "Condensed heterocyclic compounds as calcitonin agonists," introduces novel fused heterocyclic ring system compounds. This invention relates to methods for using these compounds in the treatment and prevention of various diseases or conditions, emphasizing his commitment to advancing medical science.
Career Highlights
Clifton Earl Hyman is affiliated with SmithKline Beecham Corporation, a prominent player in the pharmaceutical sector. His work at this esteemed corporation has allowed him to focus on research and development, leading to significant innovations in medication and treatment strategies.
Collaborations
Throughout his career, Hyman has collaborated with talented colleagues such as Anthony Louis Handlon and Andrew J. Carpenter. These professional relationships have fostered a dynamic environment for innovation, combining diverse expertise to tackle challenging medical issues.
Conclusion
Clifton Earl Hyman stands out as a notable figure in the pharmaceutical industry, with his innovative patents demonstrating his commitment to improving health outcomes. His collaborations and work at SmithKline Beecham Corporation reflect his significant contributions to the field, positioning him as a key inventor shaping the future of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile